首页> 外文期刊>Breast care >Role of Breast Surgery in BRCA Mutation Carriers
【24h】

Role of Breast Surgery in BRCA Mutation Carriers

机译:乳腺癌手术在BRCA突变携带者中的作用

获取原文
           

摘要

BRCA mutation carriers have a life-long breast cancer risk between 55 and 85% and a high risk of developing breast cancer at a very young age, depending on the type of mutation. The risk of developing contralateral breast cancer after a first breast cancer is elevated up to 65%, especially in case of BRCA1 mutation and young age at the first breast cancer. Since bilateral prophylactic mastectomy is associated with a risk reduction of 90–95% of developing primary or contralateral breast cancer, this option is a key point within the counseling process for patient information and shared decision-making of mutation carriers. Although the local control after breast-conserving therapy in mutation carriers seems to be comparable to that of sporadic breast cancer patients, individual patient information and counseling should include all alternative procedures of oncologically adequate mastectomy techniques and immediate reconstruction. Excellent cosmetic results, high levels of life quality, and good patient acceptance can be achieved with the recent developments in reconstructive surgery of the breast.
机译:根据突变的类型,BRCA突变携带者终生患乳腺癌的风险在55%到85%之间,很小的时候罹患乳腺癌的风险也很高。首次乳腺癌发生后发展为对侧乳腺癌的风险最高可提高到65%,尤其是在BRCA1突变和初次乳腺癌的年龄较小的情况下。由于双侧预防性乳房切除术可将患上原发性或对侧乳癌的风险降低90-95%,因此该选择是在咨询过程中为患者提供信息并共同决策突变携带者的关键。尽管在变异携带者中进行保乳治疗后的局部控制似乎与散发性乳腺癌患者的局部控制相当,但个体患者的信息和咨询应包括肿瘤学上足够的乳房切除术技术和立即重建的所有其他程序。随着乳房重建手术的最新发展,可以实现出色的美容效果,高水平的生活质量和良好的患者接受度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号